Autopsy report · NCT01530191

Factors Affecting Perioperative Outcomes

“No subject accrual”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

University of Oklahoma

Sponsor type

University, hospital or other

Conditions

Pelvic Organ Prolapse

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension
  “Low subject accrual” (76% match in meaning)
• Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle Outcomes
  “No accrual” (76% match in meaning)
• Lovaza Therapy of Peripheral Arterial Disease
  “No subject meeting criteria” (75% match in meaning)
• A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer
  “No accruals” (74% match in meaning)
• Evaluation of V.A.C. VERAFLO CLEANSE CHOICE™ Dressing Using Normal Saline to Promote Increased Healthy Wound Bed Tissue
  “Insufficient subject accrual rate” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.